Business Description

Description
Covidien PLC formerly known as Covidien Ltd. was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. In June 2009, Covidien plc announced that one of its subsidiaries has completed the acquisition of VNUS Medical Technologies, Inc. In September 2009, the Company completed the acquisition of Power Medical Interventions Inc. In November 2009, the Company completed the acquisition of Aspect Medical Systems Inc. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States. Its mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals. It operates through two segments: Medical Devices and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. The Medical Supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products. Competitors of Medical Devices segment include diversified healthcare companies, such as Johnson & Johnson, Boston Scientific, Baxter and C.R. Bard. Its Nursing Care products include: Curity and Kerlix and Medical Surgical products include: Medi-Trace. The Company holds more than 13,000 patents and have over 10,500 patent applications pending in the United States and in certain other countries that relate to aspects of the technology used in many of its products. The Company is subject to numerous federal, state and local environmental protection and health and safety laws and regulations both within and outside the United States.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.36
Equity-to-Asset 0.5
Debt-to-Equity 0.49
Debt-to-EBITDA 1.88
Interest Coverage 10.66
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.89
Distress
Grey
Safe
Beneish M-Score -2.62
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.92
Quick Ratio 1.43
Days Inventory 119.42
Days Sales Outstanding 49.47
Days Payable 40.17

Financials

FRA:6COP's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Covidien PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 8,156.652
EPS (TTM) (€) 2.976
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % 0
52-Week Range (€) 48.05 - 95
Shares Outstanding (Mil) 452.78

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Covidien PLC Filings

Filing Date Document Date Form
No Filing Data

Covidien PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Covidien PLC Frequently Asked Questions

What is Covidien PLC(FRA:6COP)'s stock price today?
The current price of FRA:6COP is €94.50. The 52 week high of FRA:6COP is €95.00 and 52 week low is €48.05.
When is next earnings date of Covidien PLC(FRA:6COP)?
The next earnings date of Covidien PLC(FRA:6COP) is .
Does Covidien PLC(FRA:6COP) pay dividends? If so, how much?
The  Dividend Yield %  of Covidien PLC(FRA:6COP) is 1.13% (As of Today), Highest Dividend Payout Ratio of Covidien PLC(FRA:6COP) was 1.43. The lowest was 0.19. And the median was 0.28. The  Forward Dividend Yield % of Covidien PLC(FRA:6COP) is 0%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release